Published in J Neuropathol Exp Neurol on March 01, 1999
Pneumococcal pneumolysin and H(2)O(2) mediate brain cell apoptosis during meningitis. J Clin Invest (2002) 2.50
Pathogenesis and pathophysiology of pneumococcal meningitis. Clin Microbiol Rev (2011) 1.87
Modulation of release of proinflammatory bacterial compounds by antibacterials: potential impact on course of inflammation and outcome in sepsis and meningitis. Clin Microbiol Rev (2002) 1.61
Steroids in bacterial meningitis: yes. J Neural Transm (Vienna) (2012) 1.48
Pneumolysin is the main inducer of cytotoxicity to brain microvascular endothelial cells caused by Streptococcus pneumoniae. Infect Immun (2001) 1.35
Cell wall-mediated neuronal damage in early sepsis. Infect Immun (2006) 1.14
Characterization of a pneumococcal meningitis mouse model. BMC Infect Dis (2012) 1.11
TRAIL limits excessive host immune responses in bacterial meningitis. J Clin Invest (2007) 1.05
Doxycycline reduces mortality and injury to the brain and cochlea in experimental pneumococcal meningitis. Infect Immun (2006) 1.04
IL-10 administration reduces PGE-2 levels and promotes CR3-mediated clearance of Escherichia coli K1 by phagocytes in meningitis. J Exp Med (2010) 1.02
Interplay of pneumococcal hydrogen peroxide and host-derived nitric oxide. Infect Immun (2006) 1.00
Pathophysiology and treatment of bacterial meningitis. Ther Adv Neurol Disord (2009) 0.98
Reprogramming the host response in bacterial meningitis: how best to improve outcome? Clin Microbiol Rev (2003) 0.95
Bacterial inhibition of phosphatidylcholine synthesis triggers apoptosis in the brain. J Exp Med (2004) 0.92
Matrix metalloproteinase inhibition lowers mortality and brain injury in experimental pneumococcal meningitis. Infect Immun (2014) 0.92
Gene expression in cortex and hippocampus during acute pneumococcal meningitis. BMC Biol (2006) 0.90
Attenuation of the bacterial load in blood by pretreatment with granulocyte-colony-stimulating factor protects rats from fatal outcome and brain damage during Streptococcus pneumoniae meningitis. Infect Immun (2004) 0.89
Bacteremia causes hippocampal apoptosis in experimental pneumococcal meningitis. BMC Infect Dis (2010) 0.89
The p53-target gene puma drives neutrophil-mediated protection against lethal bacterial sepsis. PLoS Pathog (2010) 0.87
Pneumococcal pathogenesis: "innate invasion" yet organ-specific damage. J Mol Med (Berl) (2010) 0.86
Experimental pneumococcal meningitis: impaired clearance of bacteria from the blood due to increased apoptosis in the spleen in Bcl-2-deficient mice. Infect Immun (2004) 0.84
Pneumococcal cell wall-induced meningitis impairs adult hippocampal neurogenesis. Infect Immun (2007) 0.83
Restoration of Akt activity by the bisperoxovanadium compound bpV(pic) attenuates hippocampal apoptosis in experimental neonatal pneumococcal meningitis. Neurobiol Dis (2010) 0.83
JNK is activated but does not mediate hippocampal neuronal apoptosis in experimental neonatal pneumococcal meningitis. Neurobiol Dis (2008) 0.83
Adjunctive daptomycin attenuates brain damage and hearing loss more efficiently than rifampin in infant rat pneumococcal meningitis. Antimicrob Agents Chemother (2012) 0.83
Time-dependent behavioral recovery after pneumococcal meningitis in rats. J Neural Transm (Vienna) (2010) 0.83
Host-pathogen interactions in bacterial meningitis. Acta Neuropathol (2016) 0.82
Bacterial cytolysin during meningitis disrupts the regulation of glutamate in the brain, leading to synaptic damage. PLoS Pathog (2013) 0.81
Adjunctive dexamethasone affects the expression of genes related to inflammation, neurogenesis and apoptosis in infant rat pneumococcal meningitis. PLoS One (2011) 0.81
Imipramine reverses depressive-like parameters in pneumococcal meningitis survivor rats. J Neural Transm (Vienna) (2011) 0.81
Pre-infection physical exercise decreases mortality and stimulates neurogenesis in bacterial meningitis. J Neuroinflammation (2012) 0.80
Regional differences in glutamine synthetase inhibition by L-methionine sulfoximine: a microdialysis study in the rabbit brain. Exp Brain Res (2003) 0.80
The mood-stabilizer lithium prevents hippocampal apoptosis and improves spatial memory in experimental meningitis. PLoS One (2014) 0.78
Effects of dexamethasone on aquaporin-4 expression in brain tissue of rat with bacterial meningitis. Int J Clin Exp Pathol (2015) 0.78
Vitamin B6 reduces hippocampal apoptosis in experimental pneumococcal meningitis. BMC Infect Dis (2013) 0.78
Pneumococcal meningitis: Clinical-pathological correlations (meningene-path). Acta Neuropathol Commun (2016) 0.77
Review: apoptotic mechanisms in bacterial infections of the central nervous system. Front Immunol (2012) 0.76
Dexamethasone treatment reverses cognitive impairment but increases brain oxidative stress in rats submitted to pneumococcal meningitis. Oxid Med Cell Longev (2011) 0.75
Increase in hippocampal water diffusion and volume during experimental pneumococcal meningitis is aggravated by bacteremia. BMC Infect Dis (2014) 0.75
Role of neural barriers in the pathogenesis and outcome of Streptococcus pneumoniae meningitis. Exp Ther Med (2017) 0.75
A putative role for homocysteine in the pathophysiology of acute bacterial meningitis in children. BMC Clin Pathol (2014) 0.75
Association between Experimental Bacterial Meningitis and Periapical Lesion. J Clin Diagn Res (2015) 0.75
Long-term effects from bacterial meningitis in childhood and adolescence on postural control. PLoS One (2014) 0.75
Heterogeneity of multiple sclerosis lesions: implications for the pathogenesis of demyelination. Ann Neurol (2000) 9.73
Clinical and radiographic spectrum of pathologically confirmed tumefactive multiple sclerosis. Brain (2008) 3.05
Acute axonal injury in multiple sclerosis. Correlation with demyelination and inflammation. Brain (2000) 2.90
Differentiation block of oligodendroglial progenitor cells as a cause for remyelination failure in chronic multiple sclerosis. Brain (2008) 2.83
Distinct patterns of multiple sclerosis pathology indicates heterogeneity on pathogenesis. Brain Pathol (1996) 2.41
Heterogeneity of multiple sclerosis pathogenesis: implications for diagnosis and therapy. Trends Mol Med (2001) 2.27
Erythropoietin and erythropoietin receptor in human ischemic/hypoxic brain. Acta Neuropathol (2001) 1.94
Passage of cefotaxime and ceftriaxone into cerebrospinal fluid of patients with uninflamed meninges. Antimicrob Agents Chemother (1993) 1.79
Inflammatory CNS demyelination: histopathologic correlation with in vivo quantitative proton MR spectroscopy. AJNR Am J Neuroradiol (1999) 1.75
Varicella zoster virus-associated focal vasculitis without herpes zoster: recovery after treatment with acyclovir. Neurology (1998) 1.72
Activation of caspase-3 in single neurons and autophagic granules of granulovacuolar degeneration in Alzheimer's disease. Evidence for apoptotic cell death. Am J Pathol (1999) 1.71
Pancreatic ascites: study of therapeutic options by analysis of case reports and case series between the years 1975 and 2000. Am J Gastroenterol (2003) 1.70
A quantitative analysis of oligodendrocytes in multiple sclerosis lesions. A study of 113 cases. Brain (1999) 1.63
p73 is an essential regulator of neural stem cell maintenance in embryonal and adult CNS neurogenesis. Cell Death Differ (2010) 1.60
Patterns of oligodendroglia pathology in multiple sclerosis. Brain (1994) 1.44
[Usefulness of new schemes to group Fuhrman grades in clinical practice for clear cell renal tumour]. Actas Urol Esp (2012) 1.41
Remyelination capacity of the MS brain decreases with disease chronicity. Neurology (2009) 1.39
Detection of hybrids in nature: application to oaks (Quercus suber and Q. ilex). Heredity (Edinb) (2009) 1.38
Anti-inflammatory treatment influences neuronal apoptotic cell death in the dentate gyrus in experimental pneumococcal meningitis. J Neuropathol Exp Neurol (1996) 1.36
Post-mortem studies in glioblastoma patients treated with thermotherapy using magnetic nanoparticles. Biomaterials (2008) 1.31
Penetration of rifampicin into the cerebrospinal fluid of adults with uninflamed meninges. J Antimicrob Chemother (1992) 1.27
Alkaline phosphatase isoenzymes in diagnosis. Quad Sclavo Diagn (1972) 1.22
Pharmacokinetic quantification of the exchange of drugs between blood and cerebrospinal fluid in man. Eur J Clin Pharmacol (1993) 1.22
A mouse model of Streptococcus pneumoniae meningitis mimicking several features of human disease. Acta Neuropathol (2001) 1.21
Classification of coryneform bacteria associated with human urinary tract infection (group D2) as Corynebacterium urealyticum sp. nov. Int J Syst Bacteriol (1992) 1.20
The chemokine receptor CCR2 is involved in macrophage recruitment to the injured peripheral nervous system. J Neuroimmunol (2000) 1.19
Erythropoietin: a candidate compound for neuroprotection in schizophrenia. Mol Psychiatry (2004) 1.18
Treatment of Trypanosoma cruzi-infected children with nifurtimox: a 3 year follow-up by PCR. J Antimicrob Chemother (2001) 1.15
Lipophilicity at pH 7.4 and molecular size govern the entry of the free serum fraction of drugs into the cerebrospinal fluid in humans with uninflamed meninges. J Neurol Sci (1994) 1.14
A longitudinal MRI study of histopathologically defined hypointense multiple sclerosis lesions. Ann Neurol (2001) 1.14
Large-scale production in Pichia pastoris of the recombinant vaccine Gavac against cattle tick. Vaccine (1997) 1.13
Oligodendrocyte and axon pathology in clinically silent multiple sclerosis lesions. Mult Scler (1998) 1.11
Towards establishing MS prevalence in Latin America and the Caribbean. Mult Scler (2012) 1.11
Rifampin reduces early mortality in experimental Streptococcus pneumoniae meningitis. J Infect Dis (1999) 1.10
Soluble forms of intercellular adhesion molecule-1 (ICAM-1) block lymphocyte attachment to cerebral endothelial cells. J Neuroimmunol (1995) 1.09
How a neuropsychiatric brain bank should be run: a consensus paper of Brainnet Europe II. J Neural Transm (Vienna) (2006) 1.07
Alzheimer disease: DNA fragmentation indicates increased neuronal vulnerability, but not apoptosis. J Neuropathol Exp Neurol (1998) 1.07
Intraspecific and interspecific genetic and phylogenetic relationships in the genus Populus based on AFLP markers. Theor Appl Genet (2005) 1.06
Effect of deficiency of tumor necrosis factor alpha or both of its receptors on Streptococcus pneumoniae central nervous system infection and peritonitis. Infect Immun (2001) 1.05
Immunopathology of primary hypophysitis: implications for pathogenesis. Am J Surg Pathol (2005) 1.04
Fatal PML associated with efalizumab therapy: insights into integrin αLβ2 in JC virus control. Neurology (2012) 1.04
Interleukin-6 expression in human multiple sclerosis lesions. Neurosci Lett (2000) 1.03
Expression of tyrosine kinases FAK and Pyk2 in 331 human astrocytomas. Acta Neuropathol (2004) 1.02
Clinical course, pathological correlations, and outcome of biopsy proved inflammatory demyelinating disease. J Neurol Neurosurg Psychiatry (2005) 1.01
Gene flow and hybridisation in a mixed oak forest (Quercus pyrenaica Willd. and Quercus petraea (Matts.) Liebl.) in central Spain. Heredity (Edinb) (2005) 1.01
Tumour necrosis factor alpha mRNA expression in early multiple sclerosis lesions: correlation with demyelinating activity and oligodendrocyte pathology. Glia (2000) 0.99
Modern concepts in the biology, diagnosis, differential diagnosis and treatment of primary central nervous system lymphoma. Leukemia (2011) 0.99
Molecular and morphological characterisation of Pseudococcidae surveyed on crops and ornamental plants in Spain. Bull Entomol Res (2011) 0.98
Macrophages are eliminated from the injured peripheral nerve via local apoptosis and circulation to regional lymph nodes and the spleen. J Neurosci (2001) 0.98
PINK1 mutations and parkinsonism. Neurology (2008) 0.98
Elimination of blood-derived macrophages inhibits the release of interleukin-1 and the entry of leukocytes into the cerebrospinal fluid in experimental pneumococcal meningitis. J Neuroimmunol (1997) 0.97
Moxifloxacin in the therapy of experimental pneumococcal meningitis. Antimicrob Agents Chemother (1998) 0.97
Broadened and elevated humoral immune response to EBNA1 in pediatric multiple sclerosis. Neurology (2008) 0.97
Identification of glial cell proliferation in early multiple sclerosis lesions. Neuropathol Appl Neurobiol (1998) 0.96
A prospective study of alterations in balance among patients with Parkinson's Disease. Protocol of the postural evaluation. Eur Neurol (2009) 0.96
Intracardiac thrombi complicating central total parenteral nutrition: resolution without surgery or thrombolysis. J Pediatr (1986) 0.95
Remyelination in multiple sclerosis. Mult Scler (1997) 0.95
The role of TNF-alpha during Wallerian degeneration. J Neuroimmunol (2000) 0.94
Choroid plexus: the major site of mRNA expression for the beta-trace protein (prostaglandin D synthase) in human brain. Neurosci Lett (1996) 0.94
Lessons from the neuropathology of atypical forms of multiple sclerosis. Neurol Sci (2004) 0.94
[Plasma exchange therapy for steroid-unresponsive multiple sclerosis relapses: clinical experience with 16 patients]. Nervenarzt (2006) 0.94
A clinical prediction rule for pulmonary tuberculosis in emergency departments. Int J Tuberc Lung Dis (2008) 0.93
Cerebrospinal fluid ceftazidime kinetics in patients with external ventriculostomies. Antimicrob Agents Chemother (1996) 0.93
Trovafloxacin delays the antibiotic-induced inflammatory response in experimental pneumococcal meningitis. J Antimicrob Chemother (1997) 0.93
Rifabutin for experimental pneumococcal meningitis. Chemotherapy (1997) 0.93
Macrophage differentiation antigens in acute and chronic autoimmune polyneuropathies. Brain (1998) 0.93
Molecular mechanisms of high-dose antigen therapy in experimental autoimmune encephalomyelitis: rapid induction of Th1-type cytokines and inducible nitric oxide synthase. J Immunol (2000) 0.93
Matrix metalloproteinase expression and inhibition after sciatic nerve axotomy. J Neuropathol Exp Neurol (2001) 0.93
Control of Boophilus microplus populations in grazing cattle vaccinated with a recombinant Bm86 antigen preparation. Vet Parasitol (1995) 0.91
Kinetics of piperacillin and tazobactam in ventricular cerebrospinal fluid of hydrocephalic patients. Antimicrob Agents Chemother (1997) 0.90
Myelin oligodendrocyte glycoprotein-induced experimental autoimmune encephalomyelitis in the common marmoset reflects the immunopathology of pattern II multiple sclerosis lesions. Mult Scler (2006) 0.90
Classifications and treatment responses in chronic immune-mediated demyelinating polyneuropathy. Neurology (2007) 0.90
Early hyponatraemia after pituitary surgery: cerebral salt-wasting syndrome. Eur J Endocrinol (2007) 0.90
Early expression of glutamate transporter proteins in ramified microglia after controlled cortical impact injury in the rat. Glia (2001) 0.90
Serum levels of macrophage-derived protein MRP-8/14 are elevated in active multiple sclerosis. Neurosci Lett (1998) 0.89
Increased neuronal proliferation in human bacterial meningitis. Neurology (2009) 0.89
Sarcoidosis presenting as rapidly progressive dementia: clinical and neuropathological evaluation. J Neurol (2001) 0.88
Disseminated mucormycosis caused by Absidia corymbifera leading to cerebral vasculitis. Infection (2000) 0.88
Elucidating the role of genetic drift and natural selection in cork oak differentiation regarding drought tolerance. Mol Ecol (2009) 0.88
Kinetics of ofloxacin and its metabolites in cerebrospinal fluid after a single intravenous infusion of 400 milligrams of ofloxacin. Antimicrob Agents Chemother (1994) 0.88
Multiple sclerosis: recent developments in neuropathology, pathogenesis, magnetic resonance imaging studies and treatment. Curr Opin Neurol (2001) 0.88
Effects of oncostatin M on human cerebral endothelial cells and expression in inflammatory brain lesions. J Neuropathol Exp Neurol (2001) 0.88
Escalating immunotherapy of multiple sclerosis--new aspects and practical application. J Neurol (2004) 0.88
Incorporation of low molecular weight biocides into polystyrene-divinyl benzene beads with controlled release characteristics. J Control Release (2005) 0.87
Expression of death-related proteins in dentate granule cells in human bacterial meningitis. Brain Pathol (2001) 0.87
MGMT promoter methylation status and prognosis of patients with primary or recurrent glioblastoma treated with carmustine wafers. Br J Neurosurg (2013) 0.87
Lesion development in Marburg's type of acute multiple sclerosis: from inflammation to demyelination. Mult Scler (1999) 0.87
Estimation of steady state antibiotic concentration in cerebrospinal fluid from single-dose kinetics. Eur J Clin Pharmacol (1996) 0.87
Patients with active relapsing-remitting multiple sclerosis synthesize antibodies recognizing oligodendrocyte progenitor cell surface protein: implications for remyelination. Ann Neurol (2000) 0.87
Phase I dose-escalating study of ES-285 given as a three-hour intravenous infusion every three weeks in patients with advanced malignant solid tumors. Invest New Drugs (2012) 0.86
Histopathology and serial, multimodal magnetic resonance imaging in a multiple sclerosis variant. Mult Scler (2007) 0.86
Antimicrobial peptides isolated from skin secretions of the diploid frog, Xenopus tropicalis (Pipidae). Biochim Biophys Acta (2001) 0.85
Adjuvant and immunostimulating properties of the recombinant Bm86 protein expressed in Pichia pastoris. Vaccine (1998) 0.84
Central nervous system TNFalpha-mRNA expression during rabbit experimental pneumococcal meningitis. Neurosci Lett (1997) 0.84
Electrocardiographic changes after adriamycin chemotherapy. Cancer (1979) 0.84
Novel CLN8 mutations confirm the clinical and ethnic diversity of late infantile neuronal ceroid lipofuscinosis. Clin Genet (2009) 0.84
Chronic inflammatory demyelinating polyradiculoneuropathy with histologically proven optic neuritis. Acta Neuropathol (2001) 0.84
A prediction rule to identify allocation of inpatient care in community-acquired pneumonia. Eur Respir J (2003) 0.83